Skip to content

Clinical trials

Carcinoma, Non-Small-Cell Lung trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Unknown status Clear all

1,018 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20012
20026
20033
20047
200513
200618
200720
200824
200930
201027
201125
201236
201337
201436
201542
201671
201756
201877
201979
202099
202199
202295
202360
202422

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status1,018

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University34
Betta Pharmaceuticals Co., Ltd.19
Tianjin Medical University Cancer Institute and Hospital19
National Taiwan University Hospital17
Samsung Medical Center16
Fudan University15
National Cancer Center, Korea13
Shanghai Chest Hospital13
Zhejiang Cancer Hospital13
The First Affiliated Hospital of Guangzhou Medical University12

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung1,018
Lung Neoplasms168
Brain Neoplasms32
Small Cell Lung Carcinoma28
Melanoma26
Breast Neoplasms25
Neoplasms24
Colorectal Neoplasms22
Stomach Neoplasms21
Adenocarcinoma of Lung20

Trials

Showing 76 to 100 of 1,018. Each trial links to its page on Pharma Observatory.

918 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.